New Oral Anticoagulants Market Size, Share, Value and Forecast 2034
New Oral Anticoagulants Market By Drug Type (Dabigatran (Pradaxa), Apixaban (Eliquis), Rivaroxaban (Xarelto), Betrixaban (Bevyxxa), and Edoxaban (Savaysa/Lixiana)), By Application (Pulmonary Embolism (PE), Deep Vein Thrombosis (DVT), Stroke Prevention, and Atrial Fibrillation (AF), and Others), By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, and Online Pharmacies), and By Region - Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2026 - 2034
Category: Healthcare Report Format : PDF
Pages: 229 Report Code: ZMR-10807
Published Date: Oct-2026 Status : Published
| Market Size in 2025 | Market Forecast in 2034 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 42.5 Billion | USD 79.6 Billion | 7.22% | 2025 |
Table Of Content
- Chapter 1. Preface
- 1.1 Report Description and Scope
- 1.2 Research scope
- 1.3 Research methodology
- 1.3.1 Market Research Type
- 1.3.2 Market research methodology
- Chapter 2. Executive Summary
- 2.1 Global New Oral Anticoagulants Market, (2026 - 2034) (USD Billion)
- 2.2 Global New Oral Anticoagulants Market : snapshot
- Chapter 3. Global New Oral Anticoagulants Market - Industry Analysis
- 3.1 New Oral Anticoagulants Market: Market Dynamics
- 3.2 Market Drivers
- 3.2.1 Increasing shift toward preventive care to drive market revenue in the coming years
- 3.3 Market Restraints
- 3.3.1. Health risks will limit expansion of the new oral anticoagulants industry
- 3.4 Market Opportunities
- 3.4.1. Increased regulatory approvals expected to create growth opportunities for the new oral anticoagulants market players
- 3.5 Market Challenges
- 3.5.1. High cost and limited infrastructure challenge industry growth trends
- 3.6 Porter’s Five Forces Analysis
- 3.7 Market Attractiveness Analysis
- 3.7.1 Market attractiveness analysis By Drug Type
- 3.7.2 Market attractiveness analysis By Application
- 3.7.3 Market attractiveness analysis By Distribution Channel
- Chapter 4. Global New Oral Anticoagulants Market- Competitive Landscape
- 4.1 Company market share analysis
- 4.1.1 Global New Oral Anticoagulants Market: company market share, 2025
- 4.2 Strategic development
- 4.2.1 Acquisitions & mergers
- 4.2.2 New Product launches
- 4.2.3 Agreements, partnerships, cullaborations, and joint ventures
- 4.2.4 Research and development and Regional expansion
- 4.3 Price trend analysis
- 4.1 Company market share analysis
- Chapter 5. Global New Oral Anticoagulants Market - Drug Type Analysis
- 5.1 Global New Oral Anticoagulants Market overview: By Drug Type
- 5.1.1 Global New Oral Anticoagulants Market share, By Drug Type, 2025 and 2034
- 5.2 Dabigatran (Pradaxa)
- 5.2.1 Global New Oral Anticoagulants Market by Dabigatran (Pradaxa), 2026 - 2034 (USD Billion)
- 5.3 Apixaban (Eliquis)
- 5.3.1 Global New Oral Anticoagulants Market by Apixaban (Eliquis), 2026 - 2034 (USD Billion)
- 5.4 Rivaroxaban (Xarelto)
- 5.4.1 Global New Oral Anticoagulants Market by Rivaroxaban (Xarelto), 2026 - 2034 (USD Billion)
- 5.5 Betrixaban (Bevyxxa)
- 5.5.1 Global New Oral Anticoagulants Market by Betrixaban (Bevyxxa), 2026 - 2034 (USD Billion)
- 5.6 Edoxaban (Savaysa/Lixiana)
- 5.6.1 Global New Oral Anticoagulants Market by Edoxaban (Savaysa/Lixiana), 2026 - 2034 (USD Billion)
- 5.1 Global New Oral Anticoagulants Market overview: By Drug Type
- Chapter 6. Global New Oral Anticoagulants Market - Application Analysis
- 6.1 Global New Oral Anticoagulants Market overview: By Application
- 6.1.1 Global New Oral Anticoagulants Market share, By Application, 2025 and 2034
- 6.2 Pulmonary Embolism (PE)
- 6.2.1 Global New Oral Anticoagulants Market by Pulmonary Embolism (PE), 2026 - 2034 (USD Billion)
- 6.3 Deep Vein Thrombosis (DVT)
- 6.3.1 Global New Oral Anticoagulants Market by Deep Vein Thrombosis (DVT), 2026 - 2034 (USD Billion)
- 6.4 Stroke Prevention
- 6.4.1 Global New Oral Anticoagulants Market by Stroke Prevention, 2026 - 2034 (USD Billion)
- 6.5 Atrial Fibrillation (AF)
- 6.5.1 Global New Oral Anticoagulants Market by Atrial Fibrillation (AF), 2026 - 2034 (USD Billion)
- 6.6 Others
- 6.6.1 Global New Oral Anticoagulants Market by Others, 2026 - 2034 (USD Billion)
- 6.1 Global New Oral Anticoagulants Market overview: By Application
- Chapter 7. Global New Oral Anticoagulants Market - Distribution Channel Analysis
- 7.1 Global New Oral Anticoagulants Market overview: By Distribution Channel
- 7.1.1 Global New Oral Anticoagulants Market share, By Distribution Channel, 2025 and 2034
- 7.2 Retail Pharmacies
- 7.2.1 Global New Oral Anticoagulants Market by Retail Pharmacies, 2026 - 2034 (USD Billion)
- 7.3 Hospital Pharmacies
- 7.3.1 Global New Oral Anticoagulants Market by Hospital Pharmacies, 2026 - 2034 (USD Billion)
- 7.4 Online Pharmacies
- 7.4.1 Global New Oral Anticoagulants Market by Online Pharmacies, 2026 - 2034 (USD Billion)
- 7.1 Global New Oral Anticoagulants Market overview: By Distribution Channel
- Chapter 8. New Oral Anticoagulants Market - Regional Analysis
- 8.1 Global New Oral Anticoagulants Market Regional Overview
- 8.2 Global New Oral Anticoagulants Market Share, by Region, 2025 & 2034 (USD Billion)
- 8.3. North America
- 8.3.1 North America New Oral Anticoagulants Market, 2026 - 2034 (USD Billion)
- 8.3.1.1 North America New Oral Anticoagulants Market, by Country, 2026 - 2034 (USD Billion)
- 8.3.1 North America New Oral Anticoagulants Market, 2026 - 2034 (USD Billion)
- 8.4 North America New Oral Anticoagulants Market, by Drug Type, 2026 - 2034
- 8.4.1 North America New Oral Anticoagulants Market, by Drug Type, 2026 - 2034 (USD Billion)
- 8.5 North America New Oral Anticoagulants Market, by Application, 2026 - 2034
- 8.5.1 North America New Oral Anticoagulants Market, by Application, 2026 - 2034 (USD Billion)
- 8.6 North America New Oral Anticoagulants Market, by Distribution Channel, 2026 - 2034
- 8.6.1 North America New Oral Anticoagulants Market, by Distribution Channel, 2026 - 2034 (USD Billion)
- 8.4. Europe
- 8.4.2 Europe New Oral Anticoagulants Market, 2026 - 2034 (USD Billion)
- 8.4.2.1 Europe New Oral Anticoagulants Market, by Country, 2026 - 2034 (USD Billion)
- 8.4.2 Europe New Oral Anticoagulants Market, 2026 - 2034 (USD Billion)
- 8.4 Europe New Oral Anticoagulants Market, by Drug Type, 2026 - 2034
- 8.4.1 Europe New Oral Anticoagulants Market, by Drug Type, 2026 - 2034 (USD Billion)
- 8.5 Europe New Oral Anticoagulants Market, by Application, 2026 - 2034
- 8.5.1 Europe New Oral Anticoagulants Market, by Application, 2026 - 2034 (USD Billion)
- 8.6 Europe New Oral Anticoagulants Market, by Distribution Channel, 2026 - 2034
- 8.6.1 Europe New Oral Anticoagulants Market, by Distribution Channel, 2026 - 2034 (USD Billion)
- 8.5. Asia Pacific
- 8.5.3 Asia Pacific New Oral Anticoagulants Market, 2026 - 2034 (USD Billion)
- 8.5.3.1 Asia Pacific New Oral Anticoagulants Market, by Country, 2026 - 2034 (USD Billion)
- 8.5.3 Asia Pacific New Oral Anticoagulants Market, 2026 - 2034 (USD Billion)
- 8.4 Asia Pacific New Oral Anticoagulants Market, by Drug Type, 2026 - 2034
- 8.4.1 Asia Pacific New Oral Anticoagulants Market, by Drug Type, 2026 - 2034 (USD Billion)
- 8.5 Asia Pacific New Oral Anticoagulants Market, by Application, 2026 - 2034
- 8.5.1 Asia Pacific New Oral Anticoagulants Market, by Application, 2026 - 2034 (USD Billion)
- 8.6 Asia Pacific New Oral Anticoagulants Market, by Distribution Channel, 2026 - 2034
- 8.6.1 Asia Pacific New Oral Anticoagulants Market, by Distribution Channel, 2026 - 2034 (USD Billion)
- 8.6. Latin America
- 8.6.4 Latin America New Oral Anticoagulants Market, 2026 - 2034 (USD Billion)
- 8.6.4.1 Latin America New Oral Anticoagulants Market, by Country, 2026 - 2034 (USD Billion)
- 8.6.4 Latin America New Oral Anticoagulants Market, 2026 - 2034 (USD Billion)
- 8.4 Latin America New Oral Anticoagulants Market, by Drug Type, 2026 - 2034
- 8.4.1 Latin America New Oral Anticoagulants Market, by Drug Type, 2026 - 2034 (USD Billion)
- 8.5 Latin America New Oral Anticoagulants Market, by Application, 2026 - 2034
- 8.5.1 Latin America New Oral Anticoagulants Market, by Application, 2026 - 2034 (USD Billion)
- 8.6 Latin America New Oral Anticoagulants Market, by Distribution Channel, 2026 - 2034
- 8.6.1 Latin America New Oral Anticoagulants Market, by Distribution Channel, 2026 - 2034 (USD Billion)
- 8.7. The Middle-East and Africa
- 8.7.5 The Middle-East and Africa New Oral Anticoagulants Market, 2026 - 2034 (USD Billion)
- 8.7.5.1 The Middle-East and Africa New Oral Anticoagulants Market, by Country, 2026 - 2034 (USD Billion)
- 8.7.5 The Middle-East and Africa New Oral Anticoagulants Market, 2026 - 2034 (USD Billion)
- 8.4 The Middle-East and Africa New Oral Anticoagulants Market, by Drug Type, 2026 - 2034
- 8.4.1 The Middle-East and Africa New Oral Anticoagulants Market, by Drug Type, 2026 - 2034 (USD Billion)
- 8.5 The Middle-East and Africa New Oral Anticoagulants Market, by Application, 2026 - 2034
- 8.5.1 The Middle-East and Africa New Oral Anticoagulants Market, by Application, 2026 - 2034 (USD Billion)
- 8.6 The Middle-East and Africa New Oral Anticoagulants Market, by Distribution Channel, 2026 - 2034
- 8.6.1 The Middle-East and Africa New Oral Anticoagulants Market, by Distribution Channel, 2026 - 2034 (USD Billion)
- Chapter 9. Company Profiles
- 9.1 Boehringer Ingelheim
- 9.1.1 Overview
- 9.1.2 Financials
- 9.1.3 Product Portfolio
- 9.1.4 Business Strategy
- 9.1.5 Recent Developments
- 9.2 Dr. Reddy’s Laboratories
- 9.2.1 Overview
- 9.2.2 Financials
- 9.2.3 Product Portfolio
- 9.2.4 Business Strategy
- 9.2.5 Recent Developments
- 9.3 Bristol-Myers Squibb
- 9.3.1 Overview
- 9.3.2 Financials
- 9.3.3 Product Portfolio
- 9.3.4 Business Strategy
- 9.3.5 Recent Developments
- 9.4 Sandoz
- 9.4.1 Overview
- 9.4.2 Financials
- 9.4.3 Product Portfolio
- 9.4.4 Business Strategy
- 9.4.5 Recent Developments
- 9.5 Sun Pharmaceutical Industries
- 9.5.1 Overview
- 9.5.2 Financials
- 9.5.3 Product Portfolio
- 9.5.4 Business Strategy
- 9.5.5 Recent Developments
- 9.6 Zydus Lifesciences
- 9.6.1 Overview
- 9.6.2 Financials
- 9.6.3 Product Portfolio
- 9.6.4 Business Strategy
- 9.6.5 Recent Developments
- 9.7 Pfizer Inc.
- 9.7.1 Overview
- 9.7.2 Financials
- 9.7.3 Product Portfolio
- 9.7.4 Business Strategy
- 9.7.5 Recent Developments
- 9.8 Johnson & Johnson
- 9.8.1 Overview
- 9.8.2 Financials
- 9.8.3 Product Portfolio
- 9.8.4 Business Strategy
- 9.8.5 Recent Developments
- 9.9 Teva Pharmaceutical Industries
- 9.9.1 Overview
- 9.9.2 Financials
- 9.9.3 Product Portfolio
- 9.9.4 Business Strategy
- 9.9.5 Recent Developments
- 9.10 Viatris
- 9.10.1 Overview
- 9.10.2 Financials
- 9.10.3 Product Portfolio
- 9.10.4 Business Strategy
- 9.10.5 Recent Developments
- 9.11 Lupin Limited
- 9.11.1 Overview
- 9.11.2 Financials
- 9.11.3 Product Portfolio
- 9.11.4 Business Strategy
- 9.11.5 Recent Developments
- 9.12 Teva Pharmaceutical Industries
- 9.12.1 Overview
- 9.12.2 Financials
- 9.12.3 Product Portfolio
- 9.12.4 Business Strategy
- 9.12.5 Recent Developments
- 9.13 GSK plc
- 9.13.1 Overview
- 9.13.2 Financials
- 9.13.3 Product Portfolio
- 9.13.4 Business Strategy
- 9.13.5 Recent Developments
- 9.14 Sanofi
- 9.14.1 Overview
- 9.14.2 Financials
- 9.14.3 Product Portfolio
- 9.14.4 Business Strategy
- 9.14.5 Recent Developments
- 9.15 Daiichi Sankyo
- 9.15.1 Overview
- 9.15.2 Financials
- 9.15.3 Product Portfolio
- 9.15.4 Business Strategy
- 9.15.5 Recent Developments
- 9.16 Bayer AG
- 9.16.1 Overview
- 9.16.2 Financials
- 9.16.3 Product Portfolio
- 9.16.4 Business Strategy
- 9.16.5 Recent Developments
- 9.17 and others.
- 9.17.1 Overview
- 9.17.2 Financials
- 9.17.3 Product Portfolio
- 9.17.4 Business Strategy
- 9.17.5 Recent Developments
- 9.1 Boehringer Ingelheim
Table Of Figures
- 1. Market research Type
- 2. Market research methodology
- 3. Global New Oral Anticoagulants Market, 2026 - 2034 (USD Billion)
- 4. Porter’s Five Forces Analysis
- 5. Global New Oral Anticoagulants Market attractiveness, By Drug Type
- 6. Global New Oral Anticoagulants Market attractiveness, By Application
- 7. Global New Oral Anticoagulants Market attractiveness, By Distribution Channel
- 8. Global New Oral Anticoagulants Market share by Drug Type, 2026 and 2034 (USD Billion)
- 9. Global New Oral Anticoagulants Market by Dabigatran (Pradaxa), 2026 - 2034 (USD Billion)
- 10. Global New Oral Anticoagulants Market by Apixaban (Eliquis), 2026 - 2034 (USD Billion)
- 11. Global New Oral Anticoagulants Market by Rivaroxaban (Xarelto), 2026 - 2034 (USD Billion)
- 12. Global New Oral Anticoagulants Market by Betrixaban (Bevyxxa), 2026 - 2034 (USD Billion)
- 13. Global New Oral Anticoagulants Market by Edoxaban (Savaysa/Lixiana), 2026 - 2034 (USD Billion)
- 14. Global New Oral Anticoagulants Market share by Application, 2026 and 2034 (USD Billion)
- 15. Global New Oral Anticoagulants Market by Pulmonary Embolism (PE), 2026 - 2034 (USD Billion)
- 16. Global New Oral Anticoagulants Market by Deep Vein Thrombosis (DVT), 2026 - 2034 (USD Billion)
- 17. Global New Oral Anticoagulants Market by Stroke Prevention, 2026 - 2034 (USD Billion)
- 18. Global New Oral Anticoagulants Market by Atrial Fibrillation (AF), 2026 - 2034 (USD Billion)
- 19. Global New Oral Anticoagulants Market by Others, 2026 - 2034 (USD Billion)
- 20. Global New Oral Anticoagulants Market share by Distribution Channel, 2026 and 2034 (USD Billion)
- 21. Global New Oral Anticoagulants Market by Retail Pharmacies, 2026 - 2034 (USD Billion)
- 22. Global New Oral Anticoagulants Market by Hospital Pharmacies, 2026 - 2034 (USD Billion)
- 23. Global New Oral Anticoagulants Market by Online Pharmacies, 2026 - 2034 (USD Billion)
- 24. Global New Oral Anticoagulants Market share, by Region, 2026 and 2034
- 25. North America New Oral Anticoagulants Market, 2026 - 2034 (USD Billion)
- 26. Europe New Oral Anticoagulants Market, 2026 - 2034 (USD Billion)
- 27. Asia Pacific New Oral Anticoagulants Market, 2026 - 2034 (USD Billion)
- 28. Latin America New Oral Anticoagulants Market, 2026 - 2034 (USD Billion)
- 29. The Middle-East and Africa New Oral Anticoagulants Market, 2026 - 2034 (USD Billion)
Table Of Tables
- 1. Global New Oral Anticoagulants Market: Snapshot
- 2. Drivers of the New Oral Anticoagulants Market: impact analysis
- 3. North America New Oral Anticoagulants Market revenue, By Drug Type, 2026 - 2034 (USD Billion)
- 4. North America New Oral Anticoagulants Market revenue, By Application, 2026 - 2034 (USD Billion)
- 5. North America New Oral Anticoagulants Market revenue, By Distribution Channel, 2026 - 2034 (USD Billion)
- 6. U.S. New Oral Anticoagulants Market revenue, By Drug Type, 2026 - 2034 (USD Billion)
- 7. U.S. New Oral Anticoagulants Market revenue, By Application, 2026 - 2034 (USD Billion)
- 8. U.S. New Oral Anticoagulants Market revenue, By Distribution Channel, 2026 - 2034 (USD Billion)
- 9. Canada New Oral Anticoagulants Market revenue, By Drug Type, 2026 - 2034 (USD Billion)
- 10. Canada New Oral Anticoagulants Market revenue, By Application, 2026 - 2034 (USD Billion)
- 11. Canada New Oral Anticoagulants Market revenue, By Distribution Channel, 2026 - 2034 (USD Billion)
- 12. Europe New Oral Anticoagulants Market revenue, By Drug Type, 2026 - 2034 (USD Billion)
- 13. Europe New Oral Anticoagulants Market revenue, By Application, 2026 - 2034 (USD Billion)
- 14. Europe New Oral Anticoagulants Market revenue, By Distribution Channel, 2026 - 2034 (USD Billion)
- 15. Germany New Oral Anticoagulants Market revenue, By Drug Type, 2026 - 2034 (USD Billion)
- 16. Germany New Oral Anticoagulants Market revenue, By Application, 2026 - 2034 (USD Billion)
- 17. Germany New Oral Anticoagulants Market revenue, By Distribution Channel, 2026 - 2034 (USD Billion)
- 18. France New Oral Anticoagulants Market revenue, By Drug Type, 2026 - 2034 (USD Billion)
- 19. France New Oral Anticoagulants Market revenue, By Application, 2026 - 2034 (USD Billion)
- 20. France New Oral Anticoagulants Market revenue, By Distribution Channel, 2026 - 2034 (USD Billion)
- 21. U.K. New Oral Anticoagulants Market revenue, By Drug Type, 2026 - 2034 (USD Billion)
- 22. U.K. New Oral Anticoagulants Market revenue, By Application, 2026 - 2034 (USD Billion)
- 23. U.K. New Oral Anticoagulants Market revenue, By Distribution Channel, 2026 - 2034 (USD Billion)
- 24. Italy New Oral Anticoagulants Market revenue, By Drug Type, 2026 - 2034 (USD Billion)
- 25. Italy New Oral Anticoagulants Market revenue, By Application, 2026 - 2034 (USD Billion)
- 26. Italy New Oral Anticoagulants Market revenue, By Distribution Channel, 2026 - 2034 (USD Billion)
- 27. Spain New Oral Anticoagulants Market revenue, By Drug Type, 2026 - 2034 (USD Billion)
- 28. Spain New Oral Anticoagulants Market revenue, By Application, 2026 - 2034 (USD Billion)
- 29. Spain New Oral Anticoagulants Market revenue, By Distribution Channel, 2026 - 2034 (USD Billion)
- 30. Rest of Europe New Oral Anticoagulants Market revenue, By Drug Type, 2026 - 2034 (USD Billion)
- 31. Rest of Europe New Oral Anticoagulants Market revenue, By Application, 2026 - 2034 (USD Billion)
- 32. Rest of Europe New Oral Anticoagulants Market revenue, By Distribution Channel, 2026 - 2034 (USD Billion)
- 33. Asia Pacific New Oral Anticoagulants Market revenue, By Drug Type, 2026 - 2034 (USD Billion)
- 34. Asia Pacific New Oral Anticoagulants Market revenue, By Application, 2026 - 2034 (USD Billion)
- 35. Asia Pacific New Oral Anticoagulants Market revenue, By Distribution Channel, 2026 - 2034 (USD Billion)
- 36. China New Oral Anticoagulants Market revenue, By Drug Type, 2026 - 2034 (USD Billion)
- 37. China New Oral Anticoagulants Market revenue, By Application, 2026 - 2034 (USD Billion)
- 38. China New Oral Anticoagulants Market revenue, By Distribution Channel, 2026 - 2034 (USD Billion)
- 39. Japan New Oral Anticoagulants Market revenue, By Drug Type, 2026 - 2034 (USD Billion)
- 40. Japan New Oral Anticoagulants Market revenue, By Application, 2026 - 2034 (USD Billion)
- 41. Japan New Oral Anticoagulants Market revenue, By Distribution Channel, 2026 - 2034 (USD Billion)
- 42. India New Oral Anticoagulants Market revenue, By Drug Type, 2026 - 2034 (USD Billion)
- 43. India New Oral Anticoagulants Market revenue, By Application, 2026 - 2034 (USD Billion)
- 44. India New Oral Anticoagulants Market revenue, By Distribution Channel, 2026 - 2034 (USD Billion)
- 45. South Korea New Oral Anticoagulants Market revenue, By Drug Type, 2026 - 2034 (USD Billion)
- 46. South Korea New Oral Anticoagulants Market revenue, By Application, 2026 - 2034 (USD Billion)
- 47. South Korea New Oral Anticoagulants Market revenue, By Distribution Channel, 2026 - 2034 (USD Billion)
- 48. South-East Asia New Oral Anticoagulants Market revenue, By Drug Type, 2026 - 2034 (USD Billion)
- 49. South-East Asia New Oral Anticoagulants Market revenue, By Application, 2026 - 2034 (USD Billion)
- 50. South-East Asia New Oral Anticoagulants Market revenue, By Distribution Channel, 2026 - 2034 (USD Billion)
- 51. Rest of Asia Pacific New Oral Anticoagulants Market revenue, By Drug Type, 2026 - 2034 (USD Billion)
- 52. Rest of Asia Pacific New Oral Anticoagulants Market revenue, By Application, 2026 - 2034 (USD Billion)
- 53. Rest of Asia Pacific New Oral Anticoagulants Market revenue, By Distribution Channel, 2026 - 2034 (USD Billion)
- 54. Latin America New Oral Anticoagulants Market revenue, By Drug Type, 2026 - 2034 (USD Billion)
- 55. Latin America New Oral Anticoagulants Market revenue, By Application, 2026 - 2034 (USD Billion)
- 56. Latin America New Oral Anticoagulants Market revenue, By Distribution Channel, 2026 - 2034 (USD Billion)
- 57. Brazil New Oral Anticoagulants Market revenue, By Drug Type, 2026 - 2034 (USD Billion)
- 58. Brazil New Oral Anticoagulants Market revenue, By Application, 2026 - 2034 (USD Billion)
- 59. Brazil New Oral Anticoagulants Market revenue, By Distribution Channel, 2026 - 2034 (USD Billion)
- 60. Mexico New Oral Anticoagulants Market revenue, By Drug Type, 2026 - 2034 (USD Billion)
- 61. Mexico New Oral Anticoagulants Market revenue, By Application, 2026 - 2034 (USD Billion)
- 62. Mexico New Oral Anticoagulants Market revenue, By Distribution Channel, 2026 - 2034 (USD Billion)
- 63. Rest of Latin America New Oral Anticoagulants Market revenue, By Drug Type, 2026 - 2034 (USD Billion)
- 64. Rest of Latin America New Oral Anticoagulants Market revenue, By Application, 2026 - 2034 (USD Billion)
- 65. Rest of Latin America New Oral Anticoagulants Market revenue, By Distribution Channel, 2026 - 2034 (USD Billion)
- 66. The Middle-East and Africa New Oral Anticoagulants Market revenue, By Drug Type, 2026 - 2034 (USD Billion)
- 67. The Middle-East and Africa New Oral Anticoagulants Market revenue, By Application, 2026 - 2034 (USD Billion)
- 68. The Middle-East and Africa New Oral Anticoagulants Market revenue, By Distribution Channel, 2026 - 2034 (USD Billion)
- 69. GCC Countries New Oral Anticoagulants Market revenue, By Drug Type, 2026 - 2034 (USD Billion)
- 70. GCC Countries New Oral Anticoagulants Market revenue, By Application, 2026 - 2034 (USD Billion)
- 71. GCC Countries New Oral Anticoagulants Market revenue, By Distribution Channel, 2026 - 2034 (USD Billion)
- 72. South Africa New Oral Anticoagulants Market revenue, By Drug Type, 2026 - 2034 (USD Billion)
- 73. South Africa New Oral Anticoagulants Market revenue, By Application, 2026 - 2034 (USD Billion)
- 74. South Africa New Oral Anticoagulants Market revenue, By Distribution Channel, 2026 - 2034 (USD Billion)
- 75. Rest of Middle-East Africa New Oral Anticoagulants Market revenue, By Drug Type, 2026 - 2034 (USD Billion)
- 76. Rest of Middle-East Africa New Oral Anticoagulants Market revenue, By Application, 2026 - 2034 (USD Billion)
- 77. Rest of Middle-East Africa New Oral Anticoagulants Market revenue, By Distribution Channel, 2026 - 2034 (USD Billion)
Methodology
FrequentlyAsked Questions
New oral anticoagulants (NOACs) are an emerging class of novel medicines for blood thinning.
The global new oral anticoagulants market is expected to benefit as demand for atrial fibrillation medicines and treatments grows.
According to study, the global new oral anticoagulants market size was worth around USD 42.5 billion in 2025 and is predicted to grow to around USD 79.6 billion by 2034.
The CAGR value of the new oral anticoagulants market is expected to be around 7.22% during 2026-2034.
The global new oral anticoagulants industry is projected to be challenged by high cost of treatment and ineffective healthcare infrastructure across emerging economies.
NOACs with reduced risk and integrating personalized medicine with NOACs are the emerging trends and innovations impacting the new oral anticoagulants market.
The global new oral anticoagulants market has performed well so far and will offer similar trends in the coming years.
North America will contribute notably towards the new oral anticoagulants market value.
The global new oral anticoagulants market is led by players like Boehringer Ingelheim, Dr. Reddy’s Laboratories, Bristol-Myers Squibb, Sandoz, Sun Pharmaceutical Industries, Zydus Lifesciences, Pfizer Inc., Johnson & Johnson, Teva Pharmaceutical Industries, Viatris, Lupin Limited, Teva Pharmaceutical Industries, GSK plc, Sanofi, Daiichi Sankyo, and Bayer AG.
The report explores crucial aspects of the new oral anticoagulants market, including a detailed discussion of existing growth factors and restraints, while also browsing future growth opportunities and challenges that impact the market.
HappyClients
